Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

654 toradh

  1. INDUSTRY|chemistry|chemical compound
    peinteafluarabútán Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    1,1,1,3,3-Pentafluorbutan
    de
    1,1,1,3,3-pentafluorobutane
    en
    Sainmhíniú hydrofluorocarbon [ IATE:1485219 ] with four carbon atoms and five fluorine atoms Tagairt COM-EN, based on:- U.S. Environmental Protection Agency > Ozone Layer Protection > Numbering Scheme for Ozone-Depleting Substances and their Substitutes, http://www.epa.gov/ozone/geninfo/numbers.html [19.11.2012] &- Proposal for a Regulation on fluorinated greenhouse gases /* COM/2012/0643 final - 2012/0305 (COD) */ CELEX:52012PC0643
    Nóta n.b. 1,1,1,3,3-pentafluorobutane is used in foaming agents, as a solvent and as a refrigerant.Ref.Solvay Chemicals > Products > Fluor Products > Organic Intermediates > 1,1,1,3,3-Pentafluorobutane, http://www.solvaychemicals.com/EN/products/Fluor/Organic_Intermediates/1_1_1_3_3PentafluorobutaneS365mfc.aspx [19.11.2012] & Chemical Book > 1,1,1,3,3-Pentafluorobutane (406-58-6), http://www.chemicalbook.com/ProductChemicalPropertiesCB4219648_EN.htm [19.11.2012]
    pentafluorobutane
    fr
    CF3CH2CF2CH3 | HFC-365mfc
    mul
  2. SOCIAL QUESTIONS|health|pharmaceutical industry
    (1R)-1,2-ainhidrea-4-C-(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carbocsalátai-4-cioglaiheiptilpipioraisin-2-il)-6,9-déhiodrocsa-2,6-démheitiol-11-ocsó-ocsaiciogladóideic-3-éin-1-il]peinti-1,3-dé-éin-1-il-3,5-dédí-ocsa-1-[(2R,3S)-3-hiodrocsaipeintin-2-il]-D-eiritripeinteatól Tagairt Fiontar, DCU
    ga
    (1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol
    en
  3. SOCIAL QUESTIONS|health|pharmaceutical industry
    (1S)-1,5:7,10-dé-ainhidri-12,13-bis-O-[treas-bhúitil(démheitil)silil]-2,3,4,6,8,11-heicsead-ocsai-1-2- [(2S,5S)-5-(3-hiodrocsapróipil)-3-meitilidéinteitrihidreafúráin-2-il]eitil-3-meitil-9-O- meitil-4-meitilidéin-8-[(feiniolsulfáinil)meitiol-D-arabanó-D-altra-trídeiceatól Tagairt Fiontar, DCU
    ga
    (1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylidene-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol
    en
  4. SOCIAL QUESTIONS|health|pharmaceutical industry
    (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trífhluaraimeitil)feinil]eatocsa}-3-(2-fluaraifeinil)morfóilin-4-il]meitil}-5-ocsói-2,5-déhidri-1H-1,2,4-trí-asóil-1-il)aigéad fosfónach --1-dí-ocsa-1-(meitiolaimín)-D-glúicíotól Tagairt Fiontar, DCU
    ga
    (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid -- 1-deoxy-1-(methylamino)-D-glucitol (1:2)
    en